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Validation of a Reverse
Transcription-
Polymerase Chain
Reaction-Based Five-
Gene Signature in
Non-small Cell Lung
Cancer
To the Editor:
Last year in the New England
Journal of Medicine Chen et al.1 stated
that a five-gene quantitative poly-
merase-chain-reaction assay stratified
patients with early-stage lung cancer
into low-risk and high-risk groups. In-
deed, they concluded that patient with
surgically resected non-small cell lung
cancer that were classified as first
group might be spared from adjuvant
treatment. In contrast, Michiels and
Hill2 observed that to correctly vali-
date such signature a different and
independent group of patients needed
to be used. In addition, Dobbin3 noted
that the reuse of survival data to iden-
tify a predictor genes provide substan-
tial bias. Taken together, these obser-
vations provide a rationale for an
independent validation of such molec-
ular signature. To do that, we analyzed
a population of 38 non-small cell lung
cancer patients with stage I disease
and untreated after lobar resection. Us-
ing methods as described,1 we did not
find difference among 19 patients who
had cancer-related death within 30
months after resection and 19 patients
who were alive within 40 months
after resection (5-gene high risk 
7/12 versus 8/11; Fisher’s exact test
p  1).
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ERRATUM
Results of Systematic Nodal Dissection in Typical and Atypical Carcinoid Tumors of the Lung: Erratum
In the article “Results of Systematic Nodal Dissection in Typical and Atypical Carcinoid Tumors of the Lung,” which appeared in volume 4 of the Journal
of Thoracic Oncology on pages 388–394, there was an error in Table 2. The corrected table is below. This error has also been noted in the online version
of the article, which is available at www.jto.org.
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TABLE 2. Location, Macroscopic and Microscopic Aspect of Carcinoid Tumors of
the Lung
Location Macroscopic and
Microscopic Aspect TC (42) AC (12) Total %
Central: 39 9 89
–Endoluminal 12 0 22.2
–Mural 11 1 22.2
–Peripheral 3 3 44.6
Peripheral 3 3 11
TC, Typical Carcinoid; AC, Atypical Carcinoid.
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